GSI Creos Brasil generates growth from long-term commitment to Brazil

GSI Creos is a well-respected Japanese trading company that was established in 1931 with an initial focus on silk trading — a sector closely connected to the well-being and comfort of people.

Dave (Kosuke) Yatsuyanagi, Director; Daniela Yamauti, Director and President of GSI Creos Brasil  |  © GSI Creos Brasil    

“We, as one of the affiliate companies of GSI Creos, are fortunate that the majority of our current business goes to the medical business, which brings us the opportunity to enter the chemical market in recent years,” said Dave (Kosuke) Yatsuyanagi, director of GSI Creos Brasil.

The Brazilian operation was established in 1973 as a silk production factory that changed to a trading firm in 1988. The Japanese company managed to successfully continue its operations, catering solely to Brazilian customers, which was difficult for other Japanese companies to achieve.

“For more than 40 years, GSI Creos Brasil took many risks in keeping its operations in Brazil and at one point, we had only two employees remaining. We knew it was important to keep our business operating to cater to the demand of the Japanese- Brazilian market and share our expertise in the business,” Yatsuyanagi shared.

An example of a hemodialysis treatment clinic   |  © GSI Creos Brasil  

GSI Creos Brasil’s long-term partnership with Toray Medical Co. strengthens this year as the companies started to expand hemodialysis products across South America. Currently, the company’s strongest product in Brazil is the TR-8000 hemodialysis machine.

With the majority of sales coming from the medical field, GSI Creos Brasil is eyeing increasing its revenue through investing in clinics that provide high-quality hemodialysis treatments in Brazil.

“We at GSI Creos Brasil saw the need and opportunity for high-quality hemodialysis treatments in Brazil. We are looking forward to our recent investment in clinics that offer this and will soon begin offering this around South America, as well,” Yatsuyanagi concluded.

Related Articles


Related Articles